Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Black raspberry (Rubus occidentalis) is a plant whose fruit and leaves have been used both as food and in traditional medicine. The fruit is rich in antioxidants such as anthocyanins and contains vitamins A, B, C and E. Black raspberry has been studied for its potential chemopreventive properties; laboratory studies suggest it may protect against cancer by preventing DNA changes and inhibiting tumor blood supply. It also exhibits antioxidant activity and may have pro-apoptotic (promoting cell death in abnormal cells), anti-angiogenic (blocking new blood vessel formation), hypomethylating (modifying DNA methylation patterns), diuretic and astringent effects. Traditional uses include treatment of stomach pain or bleeding; the leaves are used as a uterine tonic during pregnancy preparation or to treat diarrhea or mouth inflammation[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on black raspberry.